Cancer News and Research

Latest Cancer News and Research

Agios, Foundation Medicine announce diagnostic partnership for cancer metabolism programs

Foundation Medicine, Inc., and Agios Pharmaceuticals, Inc., today announced a multi-year diagnostic partnership for Agios' lead programs in cancer metabolism.

4 Apr 2013

First Edition: April 4, 2013

Kaiser Health News staff writer Julie Appleby, working in collaboration with USA Today, reports: "It's not just sore throats and flu shots anymore. Walgreens today became the first retail store chain to expand its health care services to include diagnosing and treating patients for chronic conditions such as asthma, diabetes and high cholesterol. The move is the retail industry's boldest push yet into an area long controlled by physicians, and comes amid continuing concerns about health care costs and a potential shortage of primary care doctors" (Appleby, 4/4).

4 Apr 2013

Researchers study specific bacteria that contribute to overactive bladder

Thousands of women suffer from overactive bladder (OAB) or the sudden need to urinate, yet many don't get relief from medication. Researchers at Loyola University Health System believe certain bacteria may be to blame.

4 Apr 2013

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Illumina, Inc. today announced the next product in its TruSight line of content sets, TruSight Tumor, for NGS-based somatic variant detection in solid tumors.

From Illumina, Inc. 4 Apr 2013

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Recently, research using adoptive T-cell immunotherapy in blood cancers have shown success, most notably in the case of a seven-year-old girl whose leukemia went into remission using altered T-cells and a disabled HIV virus.

4 Apr 2013

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Obesity causes an increase in the stiffness of the heart, making it hard for the heart muscle to relax and fill with blood in between heartbeats. This abnormal stiffness can lead to congestive heart failure and other problems as it becomes more severe.

4 Apr 2013

Molecular diagnostic testing in lung cancer offers new hope for patients

The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad.

4 Apr 2013

Same factor that helps fight off severe inflammatory ailments also functions as enemy

The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

4 Apr 2013

PharmaSeek implements Allegro CTMS to manage multiple clinical trials

Forte Research Systems, Inc., developer of specialized clinical research management software, announced that PharmaSeek, an Investigative Site Network, has implemented its Allegro Clinical Trial Management System to support their rapidly growing operations and help manage multiple trials running simultaneously.

4 Apr 2013

GWCI receives support from Susan G. Komen for the Cure to care for D.C.-area breast cancer survivors

The GW Cancer Institute is in its second year of funding from the Susan G. Komen for the Cure to help increase the quality of survivorship care for D.C.-area breast cancer survivors.

4 Apr 2013

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Physician-researchers at UT Southwestern Medical Center have identified a vulnerability of certain lung-cancer cells - a specific genetic weakness that can be exploited for new therapies.

4 Apr 2013

Finding solutions to protect U.S. troops against invisible killers

A Saint Louis University researcher has received a contract worth up to $980,000 to see if two cancer medications have the potential of protecting U.S. troops from biological agents that could be unleashed during an attack.

4 Apr 2013

Reuters examines implications of India's Novartis patent ruling for big pharma

Reuters examines the implications of India's Supreme Court ruling to reject drug maker Novartis's request for a new patent on an updated version of the cancer treatment Glivec on the pharmaceutical industry in India and across the developing world.

4 Apr 2013

More must be done to find balance between drug innovation, affordable health care

"The decision by India's Supreme Court to overturn the patent on Novartis's cancer treatment Glivec is good news for more affordable health care and bad news for drug innovation," a Financial Times editorial states, adding, "It fails fundamentally to address either issue, both of which need wide-ranging reform.

4 Apr 2013

Research finds multiple factors independently predict suicide-related behaviour in young population

New research out of St. Michael's Hospital has found that multiple factors independently predict what makes youth more likely to make repeat suicide-related behaviour.

4 Apr 2013

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

President Obama officially announced his new brain research initiative on Tuesday, with a pledge to put $100 million in his 2014 budget to support work at three federal agencies.

4 Apr 2013

UCLA Children's Discovery and Innovation Institute to drive research on children's health

For more than 60 years, the faculty and staff at Mattel Children's Hospital UCLA and the department of pediatrics at the David Geffen School of Medicine at UCLA have conducted pioneering research, delivered state-of-the-art patient care and expertly trained future pediatricians.

4 Apr 2013

Three institutions partner to create research breakthroughs in children's health

Virginia Tech, Children's National Medical Center, and the George Washington University have partnered in a unique program to create research breakthroughs in children's health.

4 Apr 2013

Researchers study effectiveness of intermittent therapy for prostate cancer treatment

Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study finds.

4 Apr 2013

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.

4 Apr 2013

Cancer News and Research

Latest Cancer News and Research

Agios, Foundation Medicine announce diagnostic partnership for cancer metabolism programs

First Edition: April 4, 2013

Researchers study specific bacteria that contribute to overactive bladder

Illumina releases TruSight Tumor for NGS-based somatic variant detection in solid tumors

Scientists develop new cancer immunotherapy treatment for children with high-risk solid tumors

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Molecular diagnostic testing in lung cancer offers new hope for patients

Same factor that helps fight off severe inflammatory ailments also functions as enemy

PharmaSeek implements Allegro CTMS to manage multiple clinical trials

GWCI receives support from Susan G. Komen for the Cure to care for D.C.-area breast cancer survivors

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Finding solutions to protect U.S. troops against invisible killers

Reuters examines implications of India's Novartis patent ruling for big pharma

More must be done to find balance between drug innovation, affordable health care

Research finds multiple factors independently predict suicide-related behaviour in young population

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

UCLA Children's Discovery and Innovation Institute to drive research on children's health

Three institutions partner to create research breakthroughs in children's health

Researchers study effectiveness of intermittent therapy for prostate cancer treatment

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in